文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高级别浆液性输卵管卵巢癌中的三级淋巴结构:解剖部位至关重要。

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

作者信息

Westbom-Fremer Sofia, Tran Lena, Ebbesson Anna, Martin de la Fuente Laura, Jönsson Jenny-Maria, Kannisto Päivi, Veerla Srinivas, Hedenfalk Ingrid

机构信息

Division of Oncology, Department of Clinical Sciences Lund, and Lund University Cancer Center, Lund University, Lund, Sweden.

Division of Obstetrics and Gynaecology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.

出版信息

Cancer Immunol Immunother. 2025 Jan 3;74(2):56. doi: 10.1007/s00262-024-03911-2.


DOI:10.1007/s00262-024-03911-2
PMID:39751944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11699021/
Abstract

Tertiary lymphoid structures (TLS) in the tumor microenvironment are prognostically beneficial in many solid cancer types. Reports on TLS in high-grade serous tubo-ovarian carcinoma (HGSC) are few, and the prognostic impact is unclear. We investigated mature TLS (mTLS), immature TLS (iTLS) and lymphoid aggregates (LA) in primary adnexal tumors (PTs) and synchronous omental/peritoneal metastases (pMets) of HGSC. Whole H&E slides were scrutinized for mTLS and LA in a population-based cohort of 130 cases with stage III-IV HGSC. The immune cell tumor infiltration was evaluated with single chromogenic immunohistochemistry (IHC) on a tissue microarray (TMA) from the same cases. Selected whole slides (PT n = 11, pMet n = 10) of the cases most abundant in mTLS and LA were further investigated with multiplex IHC and immunofluorescence using digital image analysis (QuPath), to confirm TLS status and map the T and B lymphocyte subtypes. The results showed that mTLS were more common in pMets than in PTs but did not have an independent prognostic impact on overall or progression-free survival. The presence of mTLS correlated with intratumoral infiltration of CD8 cytotoxic T cells, FOXP3 regulatory T cells and PD-1 lymphocytes in pMets only. Although overall mTLS cell composition was similar between PTs and pMets, the outer zones of mTLS in PTs were more immune cell-rich. In conclusion, our results indicate differences in TLS presence and cellular elements between primary adnexal tumors and synchronous peritoneal metastases, which are important to consider when conducting studies of the immune environment in HGSC.

摘要

肿瘤微环境中的三级淋巴结构(TLS)在许多实体癌类型中具有预后益处。关于高级别浆液性输卵管卵巢癌(HGSC)中TLS的报道很少,其预后影响尚不清楚。我们研究了HGSC原发性附件肿瘤(PTs)和同步大网膜/腹膜转移灶(pMets)中的成熟TLS(mTLS)、未成熟TLS(iTLS)和淋巴样聚集物(LA)。在一个基于人群的130例III-IV期HGSC病例队列中,对全层苏木精-伊红(H&E)切片进行mTLS和LA的仔细检查。使用来自相同病例的组织微阵列(TMA)上的单显色免疫组织化学(IHC)评估免疫细胞肿瘤浸润情况。对mTLS和LA最丰富的病例的选定全层切片(PT n = 11,pMet n = 10),使用数字图像分析(QuPath)通过多重IHC和免疫荧光进一步研究,以确认TLS状态并绘制T和B淋巴细胞亚型图谱。结果显示,mTLS在pMets中比在PTs中更常见,但对总生存期或无进展生存期没有独立的预后影响。mTLS的存在仅与pMets中肿瘤内CD8细胞毒性T细胞、FOXP3调节性T细胞和PD-1淋巴细胞的浸润相关。尽管PTs和pMets之间mTLS的总体细胞组成相似,但PTs中mTLS的外层区域免疫细胞更丰富。总之,我们的结果表明原发性附件肿瘤和同步腹膜转移灶之间TLS的存在和细胞成分存在差异,这在进行HGSC免疫环境研究时是需要考虑的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/0f21fc25bd3f/262_2024_3911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/e4be39651eb1/262_2024_3911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/961a89a6fb60/262_2024_3911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/026e4fe6da4f/262_2024_3911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/0f21fc25bd3f/262_2024_3911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/e4be39651eb1/262_2024_3911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/961a89a6fb60/262_2024_3911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/026e4fe6da4f/262_2024_3911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/0f21fc25bd3f/262_2024_3911_Fig4_HTML.jpg

相似文献

[1]
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

Cancer Immunol Immunother. 2025-1-3

[2]
Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival.

APMIS. 2021-5

[3]
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions.

Cancer Cell. 2024-11-11

[4]
Past failures and new horizons: the nuances of tertiary lymphoid structures in high-grade serous ovarian cancer may contribute to immunotherapy effectiveness.

J Immunother Cancer. 2025-4-17

[5]
PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma.

Am J Surg Pathol. 2020-8

[6]
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.

Clin Cancer Res. 2016-1-13

[7]
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer.

Clin Cancer Res. 2025-1-6

[8]
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.

Clin Cancer Res. 2015-9-18

[9]
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.

Clin Cancer Res. 2013-11-4

[10]
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.

Front Immunol. 2024

引用本文的文献

[1]
Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer.

Front Immunol. 2025-5-22

本文引用的文献

[1]
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.

Nat Commun. 2024-3-21

[2]
cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer.

NPJ Breast Cancer. 2024-1-2

[3]
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.

Cell Rep Med. 2023-6-20

[4]
Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.

Reprod Sci. 2023-8

[5]
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.

Cancer. 2023-3-1

[6]
Ovarian cancer mutational processes drive site-specific immune evasion.

Nature. 2022-12

[7]
Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer.

Cancers (Basel). 2022-12-2

[8]
The tumor immune microenvironment in peritoneal carcinomatosis.

Int Rev Cell Mol Biol. 2022

[9]
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.

JCI Insight. 2022-6-22

[10]
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.

Nat Rev Clin Oncol. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索